Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S. The Statistical Programming Director is responsible for driving the execution and oversight of the related activities across clinical studies, ensuring high-quality, compliant, and timely deliverables. This Director leads the development and implementation of CDISC-compliant datasets (SDTM, ADaM) and tables, figures, and listings (TFLs), while supporting both planned and ad-hoc analyses to address evolving clinical and business needs. The Director collaborates closely with biostatisticians and cross-functional teams to translate study objectives into efficient programming solutions, and serves as a key point of oversight for external partners, including Contract Research Organizations (CROs), ensuring consistency, accuracy, and adherence to regulatory standards. The Director also performs independent validation and quality control of programming outputs and manages multiple concurrent projects, prioritizing workstreams to meet critical timelines and support data-driven decision-making.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree